Cargando…
Netrin-1 acts as a survival factor for aggressive neuroblastoma
Neuroblastoma (NB), the most frequent solid tumor of early childhood, is diagnosed as a disseminated disease in >60% of cases, and several lines of evidence support the resistance to apoptosis as a prerequisite for NB progression. We show that autocrine production of netrin-1, a multifunctional l...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2715117/ https://www.ncbi.nlm.nih.gov/pubmed/19349462 http://dx.doi.org/10.1084/jem.20082299 |
_version_ | 1782169745412325376 |
---|---|
author | Delloye-Bourgeois, Céline Fitamant, Julien Paradisi, Andrea Cappellen, David Douc-Rasy, Setha Raquin, Marie-Anne Stupack, Dwayne Nakagawara, Akira Rousseau, Raphaël Combaret, Valérie Puisieux, Alain Valteau-Couanet, Dominique Bénard, Jean Bernet, Agnès Mehlen, Patrick |
author_facet | Delloye-Bourgeois, Céline Fitamant, Julien Paradisi, Andrea Cappellen, David Douc-Rasy, Setha Raquin, Marie-Anne Stupack, Dwayne Nakagawara, Akira Rousseau, Raphaël Combaret, Valérie Puisieux, Alain Valteau-Couanet, Dominique Bénard, Jean Bernet, Agnès Mehlen, Patrick |
author_sort | Delloye-Bourgeois, Céline |
collection | PubMed |
description | Neuroblastoma (NB), the most frequent solid tumor of early childhood, is diagnosed as a disseminated disease in >60% of cases, and several lines of evidence support the resistance to apoptosis as a prerequisite for NB progression. We show that autocrine production of netrin-1, a multifunctional laminin-related molecule, conveys a selective advantage in tumor growth and dissemination in aggressive NB, as it blocks the proapoptotic activity of the UNC5H netrin-1 dependence receptors. We show that such netrin-1 up-regulation is a potential marker for poor prognosis in stage 4S and, more generally, in NB stage 4 diagnosed infants. Moreover, we propose that interference with the netrin-1 autocrine loop in malignant neuroblasts could represent an alternative therapeutic strategy, as disruption of this loop triggers in vitro NB cell death and inhibits NB metastasis in avian and mouse models. |
format | Text |
id | pubmed-2715117 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-27151172009-10-13 Netrin-1 acts as a survival factor for aggressive neuroblastoma Delloye-Bourgeois, Céline Fitamant, Julien Paradisi, Andrea Cappellen, David Douc-Rasy, Setha Raquin, Marie-Anne Stupack, Dwayne Nakagawara, Akira Rousseau, Raphaël Combaret, Valérie Puisieux, Alain Valteau-Couanet, Dominique Bénard, Jean Bernet, Agnès Mehlen, Patrick J Exp Med Article Neuroblastoma (NB), the most frequent solid tumor of early childhood, is diagnosed as a disseminated disease in >60% of cases, and several lines of evidence support the resistance to apoptosis as a prerequisite for NB progression. We show that autocrine production of netrin-1, a multifunctional laminin-related molecule, conveys a selective advantage in tumor growth and dissemination in aggressive NB, as it blocks the proapoptotic activity of the UNC5H netrin-1 dependence receptors. We show that such netrin-1 up-regulation is a potential marker for poor prognosis in stage 4S and, more generally, in NB stage 4 diagnosed infants. Moreover, we propose that interference with the netrin-1 autocrine loop in malignant neuroblasts could represent an alternative therapeutic strategy, as disruption of this loop triggers in vitro NB cell death and inhibits NB metastasis in avian and mouse models. The Rockefeller University Press 2009-04-13 /pmc/articles/PMC2715117/ /pubmed/19349462 http://dx.doi.org/10.1084/jem.20082299 Text en © 2009 Delloye-Bourgeois et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jem.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/). |
spellingShingle | Article Delloye-Bourgeois, Céline Fitamant, Julien Paradisi, Andrea Cappellen, David Douc-Rasy, Setha Raquin, Marie-Anne Stupack, Dwayne Nakagawara, Akira Rousseau, Raphaël Combaret, Valérie Puisieux, Alain Valteau-Couanet, Dominique Bénard, Jean Bernet, Agnès Mehlen, Patrick Netrin-1 acts as a survival factor for aggressive neuroblastoma |
title | Netrin-1 acts as a survival factor for aggressive neuroblastoma |
title_full | Netrin-1 acts as a survival factor for aggressive neuroblastoma |
title_fullStr | Netrin-1 acts as a survival factor for aggressive neuroblastoma |
title_full_unstemmed | Netrin-1 acts as a survival factor for aggressive neuroblastoma |
title_short | Netrin-1 acts as a survival factor for aggressive neuroblastoma |
title_sort | netrin-1 acts as a survival factor for aggressive neuroblastoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2715117/ https://www.ncbi.nlm.nih.gov/pubmed/19349462 http://dx.doi.org/10.1084/jem.20082299 |
work_keys_str_mv | AT delloyebourgeoisceline netrin1actsasasurvivalfactorforaggressiveneuroblastoma AT fitamantjulien netrin1actsasasurvivalfactorforaggressiveneuroblastoma AT paradisiandrea netrin1actsasasurvivalfactorforaggressiveneuroblastoma AT cappellendavid netrin1actsasasurvivalfactorforaggressiveneuroblastoma AT doucrasysetha netrin1actsasasurvivalfactorforaggressiveneuroblastoma AT raquinmarieanne netrin1actsasasurvivalfactorforaggressiveneuroblastoma AT stupackdwayne netrin1actsasasurvivalfactorforaggressiveneuroblastoma AT nakagawaraakira netrin1actsasasurvivalfactorforaggressiveneuroblastoma AT rousseauraphael netrin1actsasasurvivalfactorforaggressiveneuroblastoma AT combaretvalerie netrin1actsasasurvivalfactorforaggressiveneuroblastoma AT puisieuxalain netrin1actsasasurvivalfactorforaggressiveneuroblastoma AT valteaucouanetdominique netrin1actsasasurvivalfactorforaggressiveneuroblastoma AT benardjean netrin1actsasasurvivalfactorforaggressiveneuroblastoma AT bernetagnes netrin1actsasasurvivalfactorforaggressiveneuroblastoma AT mehlenpatrick netrin1actsasasurvivalfactorforaggressiveneuroblastoma |